GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » YoY EPS Growth

Embecta (FRA:JX7) YoY EPS Growth : 105.36% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Embecta YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Embecta's YoY EPS Growth for the quarter that ended in Mar. 2024 was 105.36%.

Embecta's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was €0.46.

Embecta YoY EPS Growth Historical Data

The historical data trend for Embecta's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta YoY EPS Growth Chart

Embecta Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23
YoY EPS Growth
- -7.45 -2.87 -36.49 -70.91

Embecta Quarterly Data
Sep19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -82.12 -76.28 131.02 -44.27 105.36

Embecta YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Embecta's YoY EPS Growth for the fiscal year that ended in Sep. 2023 is calculated as:

YoY EPS Growth (A: Sep. 2023 )
=(Earnings per Share (Diluted) (A: Sep. 2023 )-Earnings per Share (Diluted) (A: Sep. 2022 ))/ | Earnings per Share (Diluted) (A: Sep. 2022 ) |
=(1.143-3.929)/ | 3.929 |
=-70.91 %

Embecta's YoY EPS Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EPS Growth (Q: Mar. 2024 )
=(Earnings per Share (Diluted) (Q: Mar. 2024 )-Earnings per Share (Diluted) (Q: Mar. 2023 )) / | Earnings per Share (Diluted) (Q: Mar. 2023 )) |
=(0.46-0.224)/ | 0.224 |
=105.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Embecta YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Embecta's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Embecta (FRA:JX7) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » YoY EPS Growth
Comparable Companies
LMAT ATRI BLFS OSUR ANIK UTMD WRBY ANGO PLSE SMTI ISRG XPAR:EL BDX TSE:7741 XSWX:ALC WST OCSE:COLO B RMD TSE:4543 XSWX:STMN
Traded in Other Exchanges
EMBC:USA JX7:Germany
Address
300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054
Website
https://www.embecta.com
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Embecta (FRA:JX7) Headlines

No Headlines